“We proactively pursued the Modification to our Supplier’s License to include cocaine back again in December 2022. We will Assess how the commercialization of the compound fits in with our enterprise model at Adastra in an effort to posture ourselves to guidance the demand for a secure source of cocaine,” Adastra explained in an announcement.